Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global dental bone graft and substitutes market, by product type (Demineralized Bone Matrix (DBM), Allograft, Xenograft, and Synthetic Bone Graft Substitutes), by material type (Collagen, Human Cell Source, Animal Source, Hydroxyapatite (Ha), Tricalcium Phosphate (TCP), and Others), by end-user (Hospitals, Clinics, and Ambulatory Surgery Centers), and by region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa), was pegged at US$ 418.4 million in 2016 and is projected to display a tremendous CAGR of 9.1% during the forecast period (2017-2025).
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/1187
Development of novel bone graft substitutes, such as bone morphogenic proteins, coupled with improvements in grafting materials and burgeoning use of autografts, is expected to propel the growth of the global dental bone graft and substitutes market over the forecast timeframe. Constant R&D programs associated with bone graft substitutes and advancement of bone grafting procedures are among the other pivotal factors aiding in the global market development.
The key market players are actively focused on the launch of new bone grafting products and related systems and accessories to cater to the growing requirements of this industry. For instance, in 2015, NovaBone Product LLC received the U.S. Food & Drug Administration (FDA) approval for the launch of its minimally invasive bone graft system, called the NovaBone MacroFORM MIS delivery system, which is specifically designed for minimally invasive orthopedic procedures. In January 2017, Citagenix, Inc. introduced the PentOS OI Max for oral and maxillofacial surgery. Furthermroe, in 2016, Glidewell Laboratories introduced a new line of dental bone grafting products under the brand, Newport Biologics. The new product line consisted of allograft and alloplast bone grafts.
Browse Press Release: https://bit.ly/2S8WHbf
Dental bone grafting procedures are introduced with the aim to facilitate surgical procedures, as well as to reduce peri-operative and post-operative complications. In November 2017, a team of researchers from the University of Minnesota introduced the Continuous Periosteal Strapping Suture (CPSS) technique, which depends on resorbable sutures and membranes to maintain the integrity of the dental bone graft. Moreover, increasing research on bioactive glass for bone grafting is contributing to the growth of the global dental bone graft and substitutes market. For instance, in 2016, engineers from Oregon State University (OSU) conducted research and reported potential effects of bioactive glass, which can reduce bacterial tendency of attacking tooth fillings.
According to a study published in the Journal of Oral Implantology in 2013, decellularized dermis matrix (DDM) coupled with mineralized cancellous bone allograft (MCAB), can guide the regeneration of bone causing stable placement of the implant.
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/1187
Global Dental Bone Graft and Substitutes Market Overview:
- Surging development of dental bone graft substitutes, and the numerous advantages offered by these substitutes over the conventional bone grafts, such as better integrity, and stability, are imperative aspects leading to the global market expansion.
- Effectiveness of synthetic substitutes to facilitate regeneration of the damaged part of the bone is expected to improve the adoption rate of these alternatives, causing a reduction in use of autografts in the surgeries restraining the growth of the market up to some extent.
- The well-known players operating in the global dental bone graft and substitutes market include Institut Straumann AG, Geistlich, DENTSPLY International, Zimmer Biomet, Medtronic Plc., BioHorizons IPH, Inc., ACE Surgical Supply Company, Inc., RTI Surgical, Inc., LifeNet Health, and Citagenix.
Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1187
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027